The launch of BrightMeds GLP-1 signifies a significant shift in how healthcare providers manage type 2 diabetes . This novel medication class offers a unique way of working that also decreases blood glucose levels but may promote weight loss and improve cardiovascular health . Early results suggest this approach be a a powerful tool for individuals